Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESTIGE-AF: DOACs vs No Anticoagulant in ICH Survivors with AF
NCT03996772Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Jun 2019
- Primary completion
- May 2024
- Countries
- 6
01
Overview
Phase 3, randomised, open-label trial in ischemic stroke, sponsored by Imperial College London. Started Jun 2019; status: completed.
02
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03996772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996772.